Puma Biotechnology, Inc.
PBYI
$8.83
$0.121.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -44.86% | -35.94% | 2.75% | 59.11% | 455.63% |
| Total Depreciation and Amortization | -2.01% | -0.97% | 0.14% | -15.99% | -14.62% |
| Total Amortization of Deferred Charges | -42.86% | -42.86% | -42.86% | -- | -- |
| Total Other Non-Cash Items | 4,948.10% | 2,255.83% | 1,410.14% | -108.20% | -102.03% |
| Change in Net Operating Assets | 58.96% | 148.37% | -185.09% | 57.35% | -658.50% |
| Cash from Operations | -7.20% | 71.35% | 7.41% | 27.32% | 32.98% |
| Capital Expenditure | 108.55% | 91.45% | -26.79% | -44.71% | -27.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.51% | -12,250.00% | -77.20% | 56.46% | 23.67% |
| Cash from Investing | -36.06% | -20,472.83% | -77.06% | 56.14% | 23.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.02% | 0.00% | -33.33% | -100.00% | -300.00% |
| Issuance of Common Stock | -100.00% | -13.33% | -13.33% | -13.33% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.11% | 0.00% | -33.33% | -99.33% | -300.00% |
| Cash from Financing | -0.65% | -0.04% | -33.54% | -100.74% | -297.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.90% | -95.59% | -157.61% | 8.64% | -288.00% |